Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Voyager Therapeutics (VYGR) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Voyager Therapeutics (VYGR) over the last 11 years, with Q3 2025 value amounting to 0.52%.

  • Voyager Therapeutics' Return on Capital Employed fell 5400.0% to 0.52% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.52%, marking a year-over-year decrease of 5400.0%. This contributed to the annual value of 0.26% for FY2024, which is 9000.0% down from last year.
  • Latest data reveals that Voyager Therapeutics reported Return on Capital Employed of 0.52% as of Q3 2025, which was down 5400.0% from 0.42% recorded in Q2 2025.
  • Over the past 5 years, Voyager Therapeutics' Return on Capital Employed peaked at 0.47% during Q4 2023, and registered a low of 0.65% during Q1 2022.
  • Over the past 5 years, Voyager Therapeutics' median Return on Capital Employed value was 0.18% (recorded in 2022), while the average stood at 0.16%.
  • In the last 5 years, Voyager Therapeutics' Return on Capital Employed tumbled by -7600bps in 2021 and then skyrocketed by 10600bps in 2023.
  • Over the past 5 years, Voyager Therapeutics' Return on Capital Employed (Quarter) stood at 0.53% in 2021, then grew by 3bps to 0.52% in 2022, then surged by 191bps to 0.47% in 2023, then plummeted by -149bps to 0.23% in 2024, then tumbled by -125bps to 0.52% in 2025.
  • Its Return on Capital Employed was 0.52% in Q3 2025, compared to 0.42% in Q2 2025 and 0.31% in Q1 2025.